Community-acquired pneumonia in children


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Community-acquired pneumonia (CAP) is still one of the most common acute infectious diseases of childhood in the world. Despite the vaccination, infant mortality from pneumonia still remains at a significant level. Timely diagnosis and the appointment of adequate antibiotic therapy are the key factors for the success of treatment and the prognosis of the disease. Despite progress in the field of laboratory and instrumental diagnosis of pneumonia, etiological diagnosis often depends on the clinical picture of the disease, and the selection of the antibiotic is carried out empirically. Objective: improve the efficiency of differential diagnosis of acute pneumonia in pediatric practice. Methods. This article presents the results of a retrospective analysis of the case histories of 140 children aged 9 months to 17 years with a diagnosis of CAP, hospitalized in the Department of Diagnostics and Rehabilitation Treatment, National Medical Research Center for Children's Health, from January 2016 to January 2020. Results. The etiological structure was assessed, the age-related characteristics of CAP were shown, the spectrum of antibacterial drugs prescribed at the prehospital stage, their dosage and effectiveness were studied. Conclusion. According to the clinical European and American guidelines, aminopenicillins are the drug of choice for the treatment of typical CAP of both pneumococcal and hemophilic etiology due to the highest activity against these pathogens and the safety of use.

Full Text

Restricted Access

About the authors

A. A Tkacheva

National Medical Research Center for Children's Health

Email: antkacheva.med@gmail.com
Pediatrician, Department of Diagnostics and Rehabilitation Treatment

A. S Polyakova

National Medical Research Center for Children's Health

M. D Bakradze

National Medical Research Center for Children's Health

V. K Tatochenko

National Medical Research Center for Children's Health

D. S Yasakov

National Medical Research Center for Children's Health

References

  1. Shah S.S., Bradley J.S. Pediatric community-acquired pneumonia. In: Cherry J.D., Harrison G.J., Kaplan S.L., Steinbach W.J., Hotez PJ., ed. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier. 2019. Chap 22.
  2. Principi N., Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax. 2011;66:815-22. Doi: 10.1136/ thx.2010.142604.
  3. Лесина О.Н., Баранова И.П., Головина Н.В., Свистунова Н.В., Кондратюк Н.Л., Предикторы тяжести внебольничных пневмоний у детей и эффективность вакцинопрофи -лактики: ретроспективное исследование. Фарматека. 2019;(1):49-54. Doi: 10.18565/ pharmateca.2019.1.49-54. doi: 10.18565/pharmateca.2019.1.49-54.
  4. World Health Organization. URL: https:// www.who.int/nnws-room/fact-sheeis/deiail/ pneumonia.
  5. Эпидемиология и вакцинопрофилактика инфекции, вызываемой Streptococcus pneumoniae. Метод. рекомендации. М., 2011. 27 с.
  6. Сергеева Е.В., Петрова С.И. Внебольничная пневмония у детей. Современные особенности. Педиатрия. 2016;3:5-10.
  7. Cardinale F, Cappiello A.R., Felicia M.M., et al. Community-acquired pneumonia in children. Early Human Development. 2013;89(Suppl. 3):S49 52. doi: 10.1016/j.esrlnumdev.2013.07.023
  8. Зайцева С.В., Зайцева О.В., Локшина Э.Э., Актуальные вопросы этиологии, диагностики и терапии внебольничной пневмонии у детей. Фарматека. 2020;27(1):46-54. Doi: 10.18565/ pnsrmstehs.2020.1.46-54. Doi: 10.18565/ pnsrmstehs.2020.1.46-54.
  9. World Health Organization. Global action plan on antimicrobial resistance. World Health Organization. 2015. URL: nttps://spps.wno.int/iris/bitstream/ handla/t 0665/193736/97S974T549563_en3. pdf?sequence=1&isAllowed=y
  10. Таточенко В.К. Болезни органов дыхания у детей. Практическое руководство. 7-е издание. М., 2019. 300 с.
  11. Чучалин А.Г. Пневмония: актуальная про блема медицины ХХI в. Пульмонология. 2015;25(2):133-42. doi: 16.18696/68790189-2015-25-2-133-142. doi: 10.18093/0879-0189-201525-2-133-142.
  12. Таточенко В.К. Резистентность бактериальной флоры и рекомендации по использованию антибиотиков при респираторных инфекциях. Фарматека. 2019;27(1):17-21. Doi: 10.185756 pnsrmstecs.2019.1.17-21. doi: 10.18575/pnsrmstecs.2019.1.17-21.
  13. Dona D., Luise D., Da Dalt L., Giaquinto C. Treatment of Community-Acquired Pneumonia: Are All Countries Treating Children in the Same Way? A Literature Review. Int J. Pediatr. 201_;2017:4239268. doi: 10.1155/201_/4239278.
  14. Willems J., Hermans E., Schelstrsete P., et al. Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review [published online ahead of print. Paediatr. Drugs. 2020;1-15. Doi: 16.166_/o462_2-626-00426-y.
  15. Rhodes A., Evans L.E., Alhazzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304-77. doi: 10.1007/s00134-017-4683-6.
  16. Le Saux N., Robinson J. Pneumonia in healthy Canadian children and youth: practice points for management. Paediatr Child Health. 2011;16(7): 417-24. doi: 10.1093/pch/16.7.417.
  17. Бакрадзе М.Д., Таточенко В.К., Полякова А.С. и др. Низкая эффективность антибиотиков, назначаемых амбулаторно детям с пневмонией и острым средним отитом, как следствие несоблюдения клинических рекомендаций. Педиатрическая фармакология. 2016;13(5):425-30. doi: 10.15690/pf. v13i5.1636. Doi: 10.15690/ pf. v13i5.1636.
  18. Спичак Т.В., Ким С.С., Катосова Л.К. Критерии диагностики и соответствие лечения внебольничных пневмоний у детей современным стандартам. Вопросы диагностики в педиатрии. 2010;2(6):31-4.
  19. Спичак Т.В. Лечение внебольничной пневмонии в амбулаторных условиях: учимся на ошибках. Медицинский совет. 2019;11:172-78. doi: 10.21518/2079-701X-2019-11-172-178. doi: 10.21518/2079-701X-2019-11-172-178.
  20. Esposito S., Patria M.F., Tagliabue C., et al. CAP in children. European respiratory monograph 63: Community-acquired pneumonia. Ed.: J. Chalmers, M. Pletz, S. Aliberti. 2014. P. 130-39.
  21. Nir-Paz R. Clinical syndromes associated with Mycoplasma pneumoniae infections. Educational Workshop 07: Mycoplasma pneumoniae: epidemiology, diagnosis and treatment. 25th ECCMID, Copenhagen, Denmark, 25 April 2015. URL: https://www.escmid.org/ESGMI
  22. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. Под ред. С.В. Яковлева, С.В. Сидоренко, В.В. Рафальского, ТВ. Спичак. М., 2016. 144 c.
  23. Bradley J.S., Byington C.L., Shah S.S., et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-76. doi: 10.1093/cid/cir531.
  24. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl. 2):ii1-23. doi: 10.1136/thoraxjnl-2011-200598
  25. Полякова А.С., Гадлия Д.Д., Хохлова ТА. и др. Антибактериальная терапия острых респираторных заболеваний. Медицинский совет. 2015;(6):24-9. doi: 10.21518/2079-701X-2015-6-24-29
  26. Приказ Министерства здравоохранения РФ от 21.03.2014, № 125н «Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям»

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies